Tower Research Capital LLC (TRC) - CANDEL THERAPEUTICS INC ownership

CANDEL THERAPEUTICS INC's ticker is and the CUSIP is 137404109. A total of 24 filers reported holding CANDEL THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of CANDEL THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$7,955
-23.6%
8,647
+4.7%
0.00%
Q2 2023$10,410
+115566.7%
8,262
+25.6%
0.00%
Q1 2023$9
-30.8%
6,576
-8.8%
0.00%
-100.0%
Q4 2022$13
-99.9%
7,214
+74.4%
0.00%
Q3 2022$13,000
+225.0%
4,137
+239.4%
0.00%
Q2 2022$4,0001,219
+2157.4%
0.00%
Q1 2022$0540.00%
Other shareholders
CANDEL THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Northpond Ventures, LLC 1,935,215$9,850,0005.31%
Sands Capital Ventures, LLC 811,737$4,132,0000.86%
Empirical Asset Management, LLC 12,000$61,0000.06%
683 Capital Management, LLC 40,929$208,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 75,000$382,0000.01%
FRANKLIN RESOURCES INC 1,125,000$5,726,0000.00%
Kestra Advisory Services, LLC 12,500$64,0000.00%
FMR LLC 1,972,226$10,039,0000.00%
High Net Worth Advisory Group LLC 300$2,0000.00%
NORTHERN TRUST CORP 13,455$68,0000.00%
View complete list of CANDEL THERAPEUTICS INC shareholders